1,256 results on '"CAMPO A"'
Search Results
2. SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic features
3. SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma
4. Decoding the molecular heterogeneity of pediatric monomorphic post–solid organ transplant lymphoproliferative disorders
5. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
6. Genetic and phenotypic attributes of splenic marginal zone lymphoma
7. Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency
8. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
9. Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry
10. CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma
11. Motive and opportunity: MYCrearrangements in high-grade B-cell lymphoma with MYCand BCL2rearrangements (an LLMPP study)
12. Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemia
13. Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks
14. A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome
15. Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions
16. Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets
17. SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma
18. Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene
19. The 2016 revision of the World Health Organization classification of lymphoid neoplasms
20. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
21. CHROMATIN ACTIVATION PROFILING OF STEREOTYPED CHRONIC LYMPHOCYTIC LEUKEMIAS REVEALS A SUBSET #8 SPECIFIC SIGNATURE
22. Laboratory Prognostic Index (LaPI) in Diffuse Large B Cell Lymphoma: Validation Study on Behalf of the Spanish Lymphoma Cooperative Group (GEL-TAMO)
23. Clinical Features and Outcome of Patients with Castleman Disease Subtypes: A Spanish Multicentric Study of 145 Patients from Geltamo
24. Clinical Characterization, Prognosis and Therapeutic Management of 181 Patients with Splenic Marginal Zone Lymphoma (SMZL): Real World Experience of the Geltamo Group
25. A Comprehensive DNA Methylome Analysis of Stereotyped and Non-Stereotyped CLL Reveals an Epigenetic Signature with Strong Clinical Impact Encompassing IGHV Status, Stereotypes and IGLV3-21R110
26. Mutations in CHD2 cause defective association with active chromatin in chronic lymphocytic leukemia
27. Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma
28. Mantle cell lymphoma: evolving management strategies
29. Chromatin activation profiling of stereotyped chronic lymphocytic leukemias reveals a subset 8–specific signature
30. Higher-order connections between stereotyped subsets
31. SOX11, CD70, and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma
32. Genomic profiling for clinical decision making in lymphoid neoplasms
33. Laboratory Prognostic Index (LaPI) in Diffuse Large B Cell Lymphoma: Validation Study on Behalf of the Spanish Lymphoma Cooperative Group (GEL-TAMO)
34. A Comprehensive DNA Methylome Analysis of Stereotyped and Non-Stereotyped CLL Reveals an Epigenetic Signature with Strong Clinical Impact Encompassing IGHV Status, Stereotypes and IGLV3-21R110
35. Whole-Genome Analysis of Histone Modifications Reveals New Insights into the Biology and Clinical Behavior of Mantle Cell Lymphoma Subtypes
36. Combination of Ibrutinib and Nivolumab Overcomes Ibrutinib Resistance in a Novel Patient-Derived Mantle Cell Lymphoma 3D Model
37. Base Editing of Hematopoietic Stem Cells Rescues T-Cell Development for CD3d Severe Combined Immunodeficiency
38. Development of a Novel Chromatin Activation Score As a Powerful Independent Prognostic Factor in Chronic Lymphocytic Leukemia
39. CRISPR-Cas9 Genome Editing of Primary Chronic Lymphocytic Leukemia Cells
40. Rituximab Maintenance after R-Bendamustine or R-CHOP in First-Line Treatment of Low-Grade Follicular Lymphoma: A Multicentre, Retrospective Study of the Spanih Group Geltamo
41. Impact of the COVID-19 Pandemic on the Incidence Registry of Hematological Neoplasms in the Region of Madrid (Spain). Preliminary Report of 2014-2021
42. Single-Cell Omics Analyses Identify the TIM-3 Ligand Galectin-9 As Novel Immunotherapy Target for Chronic Lymphocytic Leukemia
43. Clinical Characterization, Prognosis and Therapeutic Management of 181 Patients with Splenic Marginal Zone Lymphoma (SMZL): Real World Experience of the Geltamo Group
44. Clinical Features and Outcome of Patients with Castleman Disease Subtypes: A Spanish Multicentric Study of 145 Patients from Geltamo
45. Generation of Richter Transformation Models throughout Chronic Lymphocytic Leukemia Patient-Derived Xenografts: A Clonal Evolution Model
46. A Multimodal Single Cell Atlas of Human Tonsils Reveals New Insights into T and B Cell Differentiation
47. Immunocompetent 3D Follicular Lymphoma Model: A Preclinical Tool to Design Tailored Immunotherapies
48. Clonal analysis identifies hemogenic endothelium as the source of the blood-endothelial common lineage in the mouse embryo
49. SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma
50. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.